Observational studyBMC cancer2025

Efficacy and toxicity of low-doses versus standard-dose enzalutamide in advanced prostate cancer: a real-world study with implications for cancer prevention/interception.

Martino Oliva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.